Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct Thrombin Inhibitors vs LMWH in S. aureus Bacteraemia
NCT01911624Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dabigatran, argatroban in Staphylococcus aureus bacteremia (SAB), sponsored by UZ Leuven. Started Jan 2013; status: completed.
02
Drugs
dabigatranargatroban
03
Conditions
Staphylococcus aureus bacteremia (SAB)
Beyond the preview
Go deeper on NCT01911624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01911624.